You are in:Home/Publications/Intravitreal Bevacizumab Alone or Combined with Macular Laser for Treatment of Diabetic Macular Edema

Prof. Tarek Tawfek Mohamed Elsayed soliman :: Publications:

Title:
Intravitreal Bevacizumab Alone or Combined with Macular Laser for Treatment of Diabetic Macular Edema
Authors: Usama Ahmed Shalaby, Tarek Tawfik Soliman, Ayser Abd El‑Hameed Fayed
Year: 2017
Keywords: Avastin®, diffuse diabetic macular edema, photocoagulation
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper tarek.soliman01_EgyptRetinaJ_2017_4_2_37_218590.pdf
Supplementary materials Not Available
Abstract:

Purpose: We aimed to evaluate the best‑corrected visual acuity (BCVA) and assess improvement of central macular thickness (CMT) in patients with diffuse diabetic macular edema (DDME) after an intravitreal injection of bevacizumab (Avastin®) alone, or followed by modified grid macular laser photocoagulation. Subjects and Methods: This was a randomized prospective interventional study that included 78 eyes of 40 patients with DDME, divided into two groups of interventions: Group A received bevacizumab (Avastin®) injections monthly for 3 months then pro re nata, and Group B received bevacizumab as Group A but followed by grid macular laser photocoagulation 2 weeks after the first injection. Patients were observed monthly for a 12‑month period and their BCVA, intraocular pressure, and CMT were recorded. Results: Compared with the baseline, there was a significant decrease of CMT in both groups of patients (−138.3 ± 40.15 vs. −156.5 ± 33.47, respectively). The improvement in ME was more in the combined group than the Avastin® group (P < 0.0001). After 12‑month follow‑up, the mean average change in visual acuity letter score was significantly improved in both groups (P < 0.018 and < 0.002, respectively). Conclusion: Combined Avastin® and modified grid macular photocoagulation led to more stable improvement in the treatment of eyes with DDME.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus